1.6400
28-二月-25 16:45:00
15 分钟延时
股票
-0.0400
-2.38%
今日范围
1.6100 - 1.6800
ISIN
N/A
来源
NASDAQ
MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan
18 1月 2021 18:00:00 条件 Nasdaq GlobeNewswire
MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners
11 1月 2021 21:30:00 条件 Nasdaq GlobeNewswire